secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001437749-22-028937
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology sells $2.5M of common stock to CEO Alan Auerbach in private placement
--------------------------------------------------------------------------------

- Sold 568,181 shares of common stock to CEO Alan Auerbach at $4.40/share, gross proceeds ~$2.5M.
- Purchase price equaled December 9, 2022 closing price; private placement closed December 12, 2022.
- Shares issued under Section 4(a)(2) exemption, not registered under Securities Act.
- Proceeds for general corporate purposes; no specific use disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922028937/0001437749-22-028937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000143774922028937/pbyi20221212_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer